Clinical and Epidemiological Studies

  • James E. Cone
  • Gordon R. Reeve
  • Philip J. Landrigan
Part of the Life Science Monographs book series (LSMO)


Assessment of the effects on humans of exposures to hazardous chemicals relies heavily upon the results of clinical and epidemiological studies. The great advantage of such studies over animal investigations is that they provide direct evidence of the toxic actions of chemical agents in humans. Human studies are, however, difficult to conduct properly, and frequently they are difficult for policy makers to interpret (Horwitz and Feinstein, 1979; Susser, 1977). A major source of this difficulty is that almost inevitably clinical and epidemiological studies must be conducted after the occurrence of exposure. Except in rare instances, ethical constraints preclude the prospective exposure of human subjects to toxic agents (Duncan et al., 1977; U.S. Department of Health, Education, and Welfare, 1978; Rothman, 1976). Thus, the typical study of the toxicity of chemical agents in humans is observational in nature and not experimental. An additional difficulty is posed here by the complexity of the causal relationships that typically exist between toxic exposures and human disease. Not only do individual humans vary greatly in their exposure to toxicants, but they vary also in their capacity for response as well as in their exposure to factors such as alcohol and tobacco, which may modify greatly the nature or severity of their responses to toxic exposures.


Death Certificate Vinyl Chloride Standardize Mortality Ratio Calendar Period Lung Cancer Death 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alderson, M. R. 1980. Epidemiological studies of occupational carcinogens.Arch. Toxicol. Suppl. 3:3–12.CrossRefGoogle Scholar
  2. Baumgarten, M., and R. Oseasohn. 1980. Studies on occupational health: A critique.J. Occup. Med. 22:171–176.Google Scholar
  3. Beaumont, J. J., T. L. Leet, and A. H. Okun. 1981. Occupational data sets appropriate for proportionate mortality ratio analysis. Pp. 391–412 in R. Peto and M. Schneiderman, eds.Banbury Report 9. Quantification of Occupational Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.Google Scholar
  4. Berman, D. 1978.Death on the Job. Monthly Review Press, New York.Google Scholar
  5. Billmaier, D., N. Allen, B. Craft, N. Williams, S. Epstein, and R. Fontaine. 1974. Peripheral neuropathy in a coated fabrics plant. J.Occup. Med. 16:665–671.Google Scholar
  6. Center for Disease Control. 1979.Principles of Analytical Epidemiology. Center for Disease Control, Atlanta, Georgia.Google Scholar
  7. Cone, J. 1981. Sarcoidosis and beryllium disease [letter].Ann. Int. Med. 94:822.Google Scholar
  8. Creech, J. L., and M. N. Johnson. 1974. Angiosarcoma of liver in the manufacture of polyvinyl chloride.J. Occup. Med. 16: 150–151.Google Scholar
  9. Decoufle, P., T. L. Thomas, and L. W. Pickle. 1980. Comparison of the proportionate mortality ratio and the standardized mortality ratio risk measures.Am. J. Epidemiol. 111:263–269.Google Scholar
  10. Doll, R. 1958. Cancer of the lung and nose in nickel workers.Br. J. Ind. Med. 15:217–223.Google Scholar
  11. Duncan, A. S., G. R. Dunstan, and R. B. Welbourn, eds. 1977.The Dictionary of Medical Ethics. Dartoin, Longman, and Dodd, London.Google Scholar
  12. Figueroa, W. G., R. Raszowski, and W. Weiss. 1973. Lung cancer in chloromethyl methyl ether workers.N. Engl. J. Med. 228:1096–1097.CrossRefGoogle Scholar
  13. Fleiss, J. L. 1973.Statistical Methods for Rates and Proportions. Wiley, New York.Google Scholar
  14. Fox, A. J., and P. F. Collier. 1976. Low mortality rates in industrial cohort studies due to selection for work and survival in industry.Br. J. Prev. Soc. Med. 30:225–230.Google Scholar
  15. Freiman, D. G., and H. L. Hardy. 1970. Beryllium disease: The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. Beryllium Case Registry.Hum. Pathol. 1:25–44.CrossRefGoogle Scholar
  16. Greenwald, P., B. R. Friedlander, C. E. Lawrence, T. Hearne, and K. Earle. 1981. Diagnostic sensitivity bias-An epidemiologic explanation for an apparent brain tumor excess. J.Occup. Med. 23:690–692.CrossRefGoogle Scholar
  17. Honchar, P. A., and W. A. Halperin. 1981. 2,4,5-T, trichlorophenol, and soft tissue sarcomas [letter].Lancet1:268.CrossRefGoogle Scholar
  18. Horan, J. 1981. Nervous system dysfunction from exposure to 2-t-butylazo-2-hydroxy-5-methylhex-ane. (Abstract) Epidemic Intelligence Service 30th Annual Conference, April 20–24, 1981. Center for Disease Control, Atlanta, Georgia.Google Scholar
  19. Horwitz, R. I., and A. R. Feinstein. 1979. Methodologic standards and contradictory results in case-control research.Am. J. Med. 66:556–564.CrossRefGoogle Scholar
  20. Ibrahim, M. A., and W. O. Spitzer. 1979. The case-control study: The problem and the prospect.J. Chronic Dis. 32:139–144.CrossRefGoogle Scholar
  21. Jaeger, R. J. 1976. Toxicology. Public-health rounds at the Harvard School of Public Health: Vinyl chloride: Can the worker be protected?N. Engl. J. Med. 294:653–654.CrossRefGoogle Scholar
  22. Kleinbaum, D. G., L. L. Kupper, and H. Morgenstern. 1982. Epidemiologic research: Principles and quantitative methods. Chapter 2 inFundamentals of Epidemiologic Research. Lifetime Learning, Belmont, California.Google Scholar
  23. Kreiss, K., D. H. Wegman, C. A. Niles, M. B. Siroky, R. J. Krans, and R. G. Feldman. 1980. Neurologic dysfunction of the bladder in workers exposed to dimethylaminoproprionitrile.J. Am. Med. Assoc. 243:741–745.CrossRefGoogle Scholar
  24. Kupper, L. L., A. J. McMichael, M. J. Symons, and B. M. Most. 1978. On the utility of proportional mortality analysis.J. Chronic Dis. 31:15–22.CrossRefGoogle Scholar
  25. Landrigan, P. J., K. R. Wilcox, Jr., J. Silva, Jr., H. E. Humphrey, C. Kauffman, and C. W. Heath, Jr. 1979. Cohort study of Michigan residents exposed to polybrominated biphenyls: Epidemiologic and immunologic findings.Ann. N. Y. Acad. Sci. 320:284–294.Google Scholar
  26. Landrigan, P. J., K. Kreiss, C. Xintaras, R. G. Feldman, and C. W. Heath, Jr. 1980. Clinical epidemiology of occupational neurotoxic disease.Neurobehav. Toxicol. 2:43–48.Google Scholar
  27. Lewin, R. 1980. Government/industry dispute brain tumor risk.Science210:996–997.CrossRefGoogle Scholar
  28. MacMahon, B., and T. F. Pugh. 1970.Epidemiology: Principles and Methods. Little, Brown, and Co., Boston.Google Scholar
  29. Mantel, N. 1963. Chi-squares test with one degree of freedom: Extensions of the Mantel-Haenszel procedure.J. Am. Stat. Assoc. 58:690–700.Google Scholar
  30. McGlothlin, J., J. Cone, and A. Lucas. 1981. Health Hazard Evaluation Report HE 81-207-945, Metropolitan Sewer District, Cincinnati, Ohio. National Institute for Occupational Safety and Health, Cincinnati, Ohio.Google Scholar
  31. McMichael, A. J. 1976. Standardized mortality ratios and the “healthy worker effect”: Scratching beneath the surface.J. Occup. Med. 18:165–168.CrossRefGoogle Scholar
  32. Miller, R. W. 1978. The discovery of human teratogens, carcinogens and mutagens: Lessons for the future. Pp. 101–126 in A. Hollaender and F. J. DeSerres, eds.Chemical Mutagens-Priorities and Mechanisms for Their Detection,Volume 5. Plenum Press, New York.Google Scholar
  33. Monson, R. R. 1980.Occupational Epidemiology. CRC Press, Boca Raton, Florida.Google Scholar
  34. Percy, C., E. Stanek, and L. Gloeckler. 1981. Accuracy of cancer death certificates and its effect on cancer mortality studies.Am. J. Public Health71:242–250.CrossRefGoogle Scholar
  35. Pott, P. 1775.Chirugical Observations Relative to the Cataract, the Polypus of the Nose, the Cancer of the Scrotum, the Different Kinds of Ruptures, and the Mortification of the Toes and Feet. Hawes, Clark, and Collins, London.Google Scholar
  36. Rothman, K. 1976. Causes.Am. J. Epidemiol. 104:587–592.Google Scholar
  37. Rothman, K. J., and J. D. Boice. 1979.Epidemiologic Analysis with a Programmable Calculator. NIH Pub. No. 79–1649. U.S. Department of Health, Education, and Welfare, Washington, D.C.Google Scholar
  38. Rothenberg, R. 1981. Morbidity study at a chemical dump-New York.Morbid. Mortal. Weekly Rep. 30:293–294.Google Scholar
  39. Rutstein, D. D., W. Berenberg, T. C. Chalmers, C. G. Child III, A. P. Fishman, and E. B. Perrin. 1976. Measuring the quality of medical care: A clinical method.N. Engl. J. Med. 294:582–588.CrossRefGoogle Scholar
  40. Susser, M. 1973.Causal Thinking in the Health Sciences. Concepts and Strategies of Epidemiology. Oxford University Press, New York.Google Scholar
  41. Susser, M. 1977. Judgment and causal inference: Criteria in epidemiologic studies.Am. J. Epidemiol. 105:1–15.Google Scholar
  42. Taylor, J. R.,et al. 1976. Neurologic disorder induced by kepone: Preliminary report [Abstract]Neu rology26:358.Google Scholar
  43. U.S. Department of Health, Education, and Welfare. 1978. Protection of Human Subjects.Fed. Regist. 43:56174–56198.Google Scholar
  44. Waxweiler, R. J., and M. K. Haring. 1981. Comparison of proportionate mortality ratios based on company records and standardized mortality ratios based on completed cohort follow-up. Pp. 379–390 in R. Peto and M. Schneiderman, eds.Banbury Report 9: Quantification of Occupational Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.Google Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • James E. Cone
    • 1
  • Gordon R. Reeve
    • 2
  • Philip J. Landrigan
    • 3
  1. 1.Division of Occupational Medicine, Medical ServiceSan Francisco General HospitalSan FranciscoUSA
  2. 2.EpidemiologyCity of Houston Health DepartmentHoustonUSA
  3. 3.Division of Environmental and Occupational MedicineMt. Sinai Medical CenterNew YorkUSA

Personalised recommendations